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pressure, C-reactive protein and HbA1c following a standard protocol. The USDA and Phenol-Explorer
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Results: Average intake of polyphenols was 683.3 ± 5.8 mg/day. Flavonoids and phenolic acids were the
predominant classes (47.5% and 47.4%, respectively). After adjusting for potential confounders, people
with the highest intake of energy-adjusted polyphenols (upper tertile) had a more favorable cardio-
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Conclusions: Polyphenol intake is associated with a more favorable cardiovascular risk factors proﬁle,
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In the last few years, the interest for polyphenols in the ﬁeld of
human nutrition has rapidly increased for their possible beneﬁcial
effects against the development of several chronic diseases e in
particular cardiovascular diseases and diabetes [1e4] e, and in
improving cardiovascular risk factors [5e9].
Polyphenols are natural bioactive compounds mainly found in
plant-based foods, such as fruit, vegetables, legumes, cereals and
cocoa, and plant-derived beverages, such as coffee, tea and wine.
Based on the biochemical structure, ﬁve main classes of poly-
phenols with different properties and bioavailability have been
identiﬁed: ﬂavonoids (the group of polyphenols mostly studied),
phenolic acids, stilbenes, lignans and others polyphenols [10].
To date, cross-sectional and prospective epidemiological studies
have shown that the intake of total polyphenols and/or of speciﬁc
foods rich in polyphenols, such as tea, coffee, and chocolate, are
associated with a better cardiovascular risk factors proﬁle (plasma
lipids, glucose, blood pressure, platelet function, biomarkers of
inﬂammation) [11,12] and, in some cases, with a decrease in car-
diovascular diseases and diabetes incidence [13].
However, the majority of these studies have been performed in
the general population and focused on the intake of ﬂavonoids and
their subclasses; indeed data on other types of polyphenols are
scant, although they may be equally important, as suggested by
some results from the PREDIMED study. In fact, this study showed
that a high polyphenol intake, deriving especially from stilbenes
and lignans, is associated with lower risk of overall mortality [14],
whereas a high intake of total ﬂavonoids (speciﬁcally ﬂavanones
and dihydroﬂavonols) and stilbenes is associated with a reduced
risk of diabetes [15].
Inadditiontoepidemiological studies, invitroandanimaldataand
some intervention studies in humans have conﬁrmed and reinforced
the evidence for beneﬁcial effects on cardiovascular risk factors e
mainly lipid and glucose metabolism e of different polyphenols and
diets rich in polyphenols from different sources [16e21].
Considering the possible role of polyphenols in ameliorating
several cardiovascular risk factors, it is relevant to evaluate the intake
ofpolyphenolsand therelationof thedifferent classesofpolyphenols
with the cardiovascular risk factors proﬁle in people with type 2
diabetes, a population characterized by a high cardiovascular risk.
Therefore, the aim of our study was to evaluate the association
between total polyphenol intake and polyphenol classes with theet al., Polyphenol intake and
tp://dx.doi.org/10.1016/j.clnumajor cardiovascular risk factors (glucose control, lipid proﬁle,
blood pressure) and biomarkers of inﬂammation in a large popu-
lation of people with type 2 diabetes. To the best of our knowledge,
this is the ﬁrst epidemiological observational study evaluating
these aspects in type 2 diabetic patients.
2. Materials and methods
2.1. Study population
This cross-sectional study was conducted in 2573 people with
type 2 diabetes, diagnosed according to ADA criteria [22], 1535men
and 1038women, aged 50e75 years, enrolled in the TOSCA.IT study,
a randomized clinical trial designed to compare the impact of
glucose lowering drugs on cardiovascular events (http://www.
clinicaltrials.gov, study ID number: NCT00700856). The study pro-
tocol has been already published [23]. The study participants were
recruited in 60 centers distributed all over Italy. The study protocol
was approved by the Ethics Review Committee of the Coordinating
Center and of each participating center, and written informed
consent was obtained from all participants before entering the
study. For the purposes of the present analysis, baseline data e
collected prior to randomization to study treatment e were used.
Among the other parameters evaluated, body weight, height, waist
and hip circumference, blood pressure, weremeasured according to
standard procedures. Body Mass Index (BMI) was calculated as
weight (kg)/height (m2). Blood samples were obtained in the
morning after an overnight fast. All biochemical analyses were
performed in a central laboratory. Total cholesterol, HDL-
cholesterol, triglycerides and C-reactive protein (PCR) were
measured by standard methods. LDL-cholesterol was calculated
according to the Friedewald equation only for triglyceride
values < 400 mg/dl. Glycated hemoglobin (HbA1c) was measured
with High Liquid Performance Chromatography. At baseline, all
participants were treated with metformin, as per study inclusions
criteria. Data on the use of other medications were also collected.
2.2. Dietary assessment
Dietary habits were assessed with the Italian version of the Eu-
ropean Prospective Investigation into Cancer and Nutrition (EPIC)
questionnaire [24]. The questionnaire contains 248 items including
the type of fat used as seasoning, or added after cooking. The personcardiovascular risk factors in a population with type 2 diabetes: The
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consumption of each item (per day, week, month or year) and the
quantity of the food consumed, selecting the image of a food portion
showing a small, medium and large portion size, with additional
quantiﬁers (e.g. “smaller than the small portion” or “between the
small andmedium portion” etc…). The nutrient composition of the
diet was calculated with a software containing the Italian Food
Tables. Eighty-six incomplete questionnaires and questionnaires
with implausible data (i.e. energy intake less than 800 or greater
than 5000 Kcal/day) were excluded from the analyses.
2.3. Estimation of polyphenol intake
The intake of polyphenols and their classes was evaluated using
the USDA database [25] in combination with the Phenol-Explorer®
database [26] to enable the examination of the polyphenol content
of as many foods as possible. Missing data from cereal products,
such as pizza, polenta, biscuits, crisp toasts, crackers and bread-
sticks, were estimated based on reﬁned wheat ﬂour data from
Phenol-Explorer® database. For processed foods such as canned
foods and pre-packaged meals, the estimation was made according
to the percentages of ingredients in the food products. Complex
foods such as cakes and sauces were calculated as recipes; the in-
dividual ingredients were obtained from data available on the
Internet. Different types of coffee, “espresso” and “decaffeinated”,
were reported in the food frequency questionnaire. The polyphenol
content of ‘‘espresso’’ coffee was estimated on the coffee brand
frequently used in Italy; therefore, the mean polyphenol content in
the Arabica and Robusta varieties from the Phenol-Explorer data-
base was calculated and multiplied by 2 to avoid underestimation
of polyphenol from coffee espresso, as suggested by Parras [27]. For
“decaffeinated” coffee, the polyphenol content of “decaffeinated
ﬁltered coffee” from the Phenol-Explorer database was considered.
The polyphenol composition of tea was obtained from a mix of
herbal teas considering the unspeciﬁed type of herbal tea in the
food frequency questionnaire (FFQ).
Finally, individual polyphenol intake from each food was
calculated by multiplying the content of each polyphenol by the
daily consumption of each food. Mean intake of each polyphenol
class (ﬂavonoids, phenolic acids, stilbenes, lignans and other
polyphenols) was determined. Total polyphenol intake was calcu-
lated as the sum of all individual polyphenol intakes from all the
food sources reported by the FFQ.
The cut-off used for foods to be included in the polyphenol esti-
mation was based on a previous study which referred to foods that
contributed <1 mg/day to the overall polyphenol intake as minor
contributors. Thus, foods containing less than1mgofpolyphenols as
consumed in a usual portion were excluded from the analysis.
2.4. Statistical analysis
Data from continuous variables are presented as
mean ± standard deviation. Percentages are used for categorical
variables. Not normally distributed variables were logarithmicallyTable 1
Percentage contribution of different classes to the total polyphenol intake and main food
Contribution (%) Main food sources in the cohort (% of
Flavonoids 47.5 Fruit (32.2%), Alcoholic beveragesa (2
Phenolic acids 47.4 Non-alcoholic beveragesb (65.3%), Fru
Stilbenes .8 Alcoholic beveragesa (97.1%)
Lignans .5 Fruit (85.4%), Vegetables (6.4%), Fat a
Other Polyphenols 3.8 Fat and oils (52.2%), Cereal products (
a Alcoholic Beverages: wine and beer.
b Non-alcoholic beverages: coffee and tea.
Please cite this article in press as: Vitale M, et al., Polyphenol intake and
TOSCA.IT study, Clinical Nutrition (2016), http://dx.doi.org/10.1016/j.clnutransformed for statistical analyses and back-transformed to nat-
ural units for presentation in the text and tables.
Polyphenol intake is reported as mg of polyphenols per
1000 kcal to correct for total energy intake, which was higher in
subjects with increased polyphenol consumption. Baseline char-
acteristics and metabolic proﬁle have been evaluated across tertiles
of total polyphenol intake and of the two main polyphenol classes
(ﬂavonoids and phenolic acids). Differences between tertiles were
tested by a one-factor analysis of variance (ANOVA) and Post-Hoc
test for multiple comparisons (Bonferroni Test) for continuous
variables, and by the chi-square test for categorical variables. The
analysis was adjusted for gender, age, and all the variables which
were signiﬁcantly different between tertiles, i.e. BMI, waist and hip
circumferences, smoke, alcohol intake, dietary lipids, saturated e
SFA -, monounsaturated e MUFA -, and polyunsaturated e PUFA-
fatty acids, added sugars and ﬁber intake.
All P-values reported were based on two-sided tests, the sig-
niﬁcance level was set at .05. IBM SPSS Statistic 20 (SPSS Inc.,
Chicago, IL, USA) software was used for all the statistical analysis.
3. Results
The total polyphenol intake of our population was
683.3 ± 5.8 mg/day and, adjusting for energy intake, it was
378.7 ± 4.1 mg/1000 Kcal for men and 374.0 ± 4.9 mg/1000 Kcal for
women, with no difference between genders. Flavonoids and
phenolic acids represented the two main classes of polyphenol
intake in our population, accounting for 95% of the total polyphenol
intake (respectively 47.5% and 47.4%); the remaining 5.1% was
represented by the others three classes (other polyphenols, stil-
benes, and lignans, respectively 3.8%, .8%, and .5%) (Table 1).
Dividing the population according to tertiles of energy-adjusted
polyphenol intake, signiﬁcant differences in some demographic
characteristics and in the nutrient composition of the diets were
observed (Table 2). In fact, participants with a higher polyphenol
intake were older, had lower BMI, waist and hip circumferences,
were more likely to be smokers and consumed more alcoholic
beverages (mostly wine and beer) (p < .05 for all). In addition, a
higher intake of polyphenols was associated, at least to some
extent, to better diet quality. In fact, a lower intake of saturated fatty
acids and a higher intake of unsaturated fatty acids and ﬁber were
associated with a higher consumption of polyphenols (p < .001 for
all). The groups did not differ in terms of gender distribution and
use of lipid and pressure lowering drugs.
Figure 1 shows the metabolic proﬁle, blood pressure values and
CRP according to the tertiles of energy-adjusted polyphenol intake.
After adjusting for the potential confounders (gender, age, BMI,
waist and hip circumferences, smoking, and all nutrients resulted
different across the tertiles of energy-adjusted polyphenol intake),
people in the higher tertile of energy-adjusted polyphenol intake
(tertile 3) showed signiﬁcantly higher HDL-cholesterol and lower
LDL-cholesterol, triglycerides, systolic and diastolic blood pressure,
HbA1c, and CRP compared to subjects in the lower tertiles (tertiles
1 and 2) (p < .001 for all, analysis of variance and post-hoc test forsources for each class.
total intake within each polyphenol class)
2.8%), Non-alcoholic beveragesb (17.6%), Vegetables (15.1%), Legumes (7.5%)
it (15.1%), Vegetables (10.9%), Alcoholic beveragesa (4.4%), Cereal products (3.5%)
nd oils (6.3%)
28.5%), Alcoholic beveragesa (13.0%), Non-alcoholic beveragesb (6.3%)
cardiovascular risk factors in a population with type 2 diabetes: The
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Table 2
Baseline characteristics and nutrient composition of the diet according to energy-adjusted tertiles of polyphenol intake.
Tertile 1 (n 856) Tertile 2 (n 860) Tertile 3 (n 858) P for Anova or c2
Total polyphenols (mg/1000 kcal) 228.5 ± 50.8
(51.8e297.7)
355.0 ± 32.8
(297.9e413.7)
546.4 ± 150.1
(413.7e1628.6)
Gender
Males (%) 59.4 58.4 61.2 .865
Females (%) 40.6 41.6 38.8 .912
Age (years) 61.9 ± 6.5 61.9 ± 6.4 62.5 ± 6.4 .041
BMI (kg/m2) 30.7 ± 4.5 30.3 ± 4.4 29.9 ± 4.4 <.0001
Waist Circumference (cm) 105.5 ± 11.3 104.3 ± 11.6 103.6 ± 10.6 .002
Hip circumference (cm) 107.2 ± 10.7 106.4 ± 10.4 105.6 ± 9.5 .005
Smoking status (%)
Non smoker 85.8 82.7 79.6 .009
Current smoker 14.2 17.3 20.4 .032
% on lipid lowering medications 56.7 61.3 68.1 .082
% on pressure lowering medications 93.2 92.9 91.2 .231
Proteins (% of TE) 18.3 ± 2.4 18.3 ± 2.4 18.1 ± 2.7 .368
Lipids (% of TE) 36.3 ± 5.9 36.8 ± 5.6 36.9 ± 6.4 .014
SFA (% of TE) 12.4 ± 2.6 12.3 ± 2.4 11.8 ± 2.4 <.0001
MUFA (% of TE) 17.4 ± 3.5 17.8 ± 3.4 18.3 ± 4.1 <.0001
PUFA (% of TE) 4.3 ± 1.1 4.4 ± 1.0 4.6 ± 1.2 <.0001
Carbohydrates (% of TE) 45.4 ± 7.1 44.9 ± 6.9 45.1 ± 7.6 .353
Added sugars (% of TE) 2.1 ± 2.9 2.4 ± 2.8 2.6 ± 3.7 .002
Fiber (g/1000 kcal) 9.4 ± 2.1 10.7 ± 2.4 12.1 ± 2.9 <.0001
Alcohol (g/day) 8.0 ± 13.9 11.0 ± 14.4 14.4 ± 18.5 <.0001
M ± SD.
TE: Total Energy of the diet.
p < .05 vs tertile 3, Post-Hoc Test for multiple comparisons (Bonferroni Test).
M. Vitale et al. / Clinical Nutrition xxx (2016) 1e74multiple comparisons). Moreover, a signiﬁcant linear trend was
observed (p < .001 for all).
The proportion of study participants on lipid lowering agents
was equally distributed across the tertiles of polyphenol intake;
however, a sensitivity analysis conducted with the exclusion of
people on hypolipidemic drugs conﬁrmed all the previous ﬁndings
(Supplemental Table 1).Fig. 1. Metabolic proﬁle, blood pressure values and C-reactive protein according to t
Please cite this article in press as: Vitale M, et al., Polyphenol intake and
TOSCA.IT study, Clinical Nutrition (2016), http://dx.doi.org/10.1016/j.clnuFlavonoids and phenolic acids were the two main contributors
to the total polyphenol intake in our population; therefore, we
analyzed the metabolic variables also according to tertiles of
energy-adjusted intake of each of these two classes of polyphenols.
The ﬁndings were the same as those found with total polyphenol
intake (Tables 3 and 4), except for HbA1c, which was no longer
signiﬁcantly related to phenolic acid intake (Table 4).ertiles of energy-adjusted polyphenol intake ( tertile 1; tertile 2; tertile 3).
cardiovascular risk factors in a population with type 2 diabetes: The
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Table 3
Metabolic proﬁle, blood pressure values and C-reactive protein according to energy adjusted tertiles of ﬂavonoid intake.
Tertile 1 (n 856) Tertile 2 (n 860) Tertile 3 (n 858) P for Anova
Flavonoids (mg/1000 Kcal) 86.1 ± 23.9
(16.3e121.5)
156.2 ± 21.1
(121.6e193.9)
286.7 ± 118.8
(194.0e1181.3)
LDL-cholesterol (mg/dl) 103.3 ± 3.8 103.0 ± 3.9 102.1 ± 3.9 2.2  108
Triglycerides (mg/dl) 152.9 ± 18.4 150.7 ± 16.9 148.3 ± 17.4 6.5  108
HDL-cholesterol (mg/dl) 45.2 ± 4.8 46.2 ± 4.4 47.0 ± 4.3 5.3  1015
HbA1c (%) 7.69 ± .09 7.69 ± .08 7.67 ± .08 2.1  107
Systolic pressure (mm/Hg) 135.2 ± 3.4 134.5 ± 3.4 134.6 ± 3.5 1.9  104
Diastolic pressure (mm/Hg) 80.5 ± 1.7 80.0 ± 1.7 79.7 ± 1.8 3.4  1018
CRP (mg/dl) 1.29 ± .15 1.28 ± .15 1.25 ± .14 4.3  1010
M ± SD.
p < .05 vs tertile 3, Post-Hoc Test for multiple comparisons (Bonferroni Test).
Data adjusted for gender, age, BMI, waist and hip circumferences, smoke, alcohol intake, dietary lipids, SFA, MUFA, PUFA, added sugars and ﬁber.
Table 4
Metabolic proﬁle, blood pressure values and C-reactive protein according to energy adjusted tertiles of phenolic acids intake.
Tertile 1 (856) Tertile 2 (860) Tertile 3 (858) P for Anova
Phenolic acids (mg/1000 Kcal) 96.8 ± 29.3
(18.6e137.5)
167.2 ± 18.2
(137.6e201.5)
281.5 ± 92.0
(201.6e1170.1)
LDL-cholesterol (mg/dl) 103.0 ± 3.8 102.9 ± 3.9 102.5 ± 4.1 5.1  104
Triglycerides (mg/dl) 152.0 ± 17.2 150.9 ± 17.4 148.9 ± 18.3 7.2  109
HDL-cholesterol (mg/dl) 45.8 ± 4.7 46.1 ± 4.4 46.7 ± 4.6 1.6  105
HbA1c (%) 7.69 ± .08 7.68 ± .08 7.68 ± .08 .217
Systolic pressure (mm/Hg) 135.5 ± 3.4 134.8 ± 3.4 134.0 ± 3.4 3.1  1019
Diastolic pressure (mm/Hg) 80.4 ± 1.7 80.1 ± 1.6 79.5 ± 1.8 1.4  1029
CRP (mg/dl) 1.29 ± .15 1.27 ± .15 1.26 ± .15 1.2  107
M ± SD.
p < .05 vs tertile 3, Post-Hoc Test for multiple comparisons (Bonferroni Test).
Data adjusted for gender, age, BMI, waist and hip circumferences, smoke, alcohol intake, dietary lipids, SFA, MUFA, PUFA, added sugars and ﬁber.
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This is the ﬁrst epidemiological observational study evaluating
the association between polyphenol intake and major cardiovas-
cular risk factors e glucose control, lipid proﬁle, blood pressure e
and a biomarker of subclinical inﬂammation (PCR) in people with
type 2 diabetes.
Themain andmost relevantﬁndings of this studywere that a diet
characterized by a higher intake of total polyphenolswas associated
with a better cardiovascular risk factors proﬁle and a lower grade of
subclinical inﬂammation. These ﬁndingswere independent of other
dietary components and potential confounders, such as gender, age,
BMI, and smoking;moreover, the associationswere evident also in a
population at very high cardiovascular risk, who followed amore or
less quite homogeneous diet not characterized by a high intake of
polyphenols, and who were already on pharmacological treatment
for their main cardiovascular risk factors. In addition to the associ-
ations with total polyphenol intake, also the consumption of ﬂavo-
noids and phenolic acids e the two main classes of polyphenols
consumed by our population ewere signiﬁcantly associated with a
better cardiovascular proﬁle, with the only exception of blood
glucose control forphenolic acids. This difference couldbe explained
either by a possible minor inﬂuence of phenolic acids on blood
glucose metabolism, which should be better investigated in inter-
vention studies, or,more likely, by confounders linked speciﬁcally to
the intake of phenolic acids. As amatter of fact, themain contributor
to phenolic acids intake is represented by non-alcoholic beverages
and the added sugars generally utilized in these drinks could have
counteracted or masked the relationship between phenolic acids
and glucose control.Within this context, it is important to underline
that in the same population a positive association was found be-
tween added sugars and HbA1c concentrations [28].
Inverse associations between polyphenols, in particular ﬂavo-
noids, some foods rich in selected polyphenols (fruit and vegeta-
bles, coffee, tea, etc.) and cardiovascular risk factors and/orPlease cite this article in press as: Vitale M, et al., Polyphenol intake and
TOSCA.IT study, Clinical Nutrition (2016), http://dx.doi.org/10.1016/j.clnucardiovascular events in the general population have been already
reported [11e13]. Our study reinforces, in a different population,
the data on ﬂavonoids, extends the results to the other main class of
polyphenols e i.e., the phenolic acids e and shows an inverse as-
sociation also with markers of systemic subclinical inﬂammation.
Of course, the cross-sectional nature of our study does not allow
us to infer a causal effect of polyphenols on the different outcomes.
However, intervention studies in humans and in vitro and animal
studies support thishypothesis. In fact, intervention trialswithsingle
foods/beverages rich in polyphenols (tea, chocolate and cocoa, cof-
fee, wine, orange juice) or extracts of speciﬁc polyphenols indicate
positive effects on cardiovascular risk factors (plasma lipids, glucose
metabolism, blood pressure) and an improvement of the endothelial
function [16,29,30]. Very recent data show that a diet naturally rich
in polyphenols from different sources improves post-prandial lipid
metabolism, oxidative stress, and glucose tolerance in metabolically
high-risk patients, strongly supporting the possible causal effect of
different polyphenols onmultiple cardiovascular risk factors [18,19].
Moreover, there are also different plausible mechanisms possibly
explaining the link between polyphenols and cardiovascular risk
factors, which reinforce the possibility of a causal relation. Themain
one are slow-down in the digestion and absorption of lipids and
glucose, increase in insulin secretion and/or decrease in insulin
resistance, decrease in oxidative stress and subclinical inﬂammation,
increase in nitric oxide bioavailability with subsequent vasodilata-
tion effect [5,9,31]. Data on the association betweenhigh polyphenol
intake and lower BMI, waist and hip circumferences, are really
interesting and in linewith someevidences showingapossible effect
of polyphenol in increasing energy expenditure [32]. However, they
cannot explain the association between polyphenol and cardiovas-
cular risk factors in our study because the above associations have
been found after adjusting for BMI, waist and hip circumferences.
The differences inmetabolic proﬁle, blood pressure, andmarkers
of inﬂammation among the different tertiles of polyphenols and
their main classes are statistically signiﬁcant but their magnitude iscardiovascular risk factors in a population with type 2 diabetes: The
.2016.11.002
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the level of the individual patient; however, it could be relevant
when translated at the population level. Moreover, considering the
differencesbetween tertilesof polyphenol intake in LDL-cholesterol,
triglycerides, HDL-cholesterol and blood pressure, on the basis of
prospective and intervention studies [33e37] it is possible to foresee
an 11% reduction in the cardiovascular risk, which is certainly of
clinical relevance taking also into account that this reduction is
linked to only one component of the diet. Furthermore, from a
practical point of view, themain sources of polyphenols in the diet of
our population are represented by non-alcoholic beverages, such as
tea and coffee (39.5%), fruit (23.0%), alcoholic beverages (13.9%),
vegetables (12.4%), legumes (3.7%) which, except for alcoholic bev-
erages, represent a good source of nutrients and other bioactive
compounds able to positively inﬂuence cardiovascular risk factors.
Of course, our study has strengths and limitations.
The large size of the study sample, the selection of a cohort
representative of the diabetic population seen in everyday clinical
practice, the standardized collection of nutritional data, the
centralized measurements of the biochemical variables, and the
analysis of different classes of polyphenols, are the major strengths.
Among the limitations, the ﬁrst one is represented by the cross-
sectional design of the study, although, as reported previously,
intervention and mechanistic studies support a possible causal
relation. Other limitations may be linked to the estimation of
polyphenol intake: variability or lack of information on polyphenol
content in foods depending on ripeness at harvest time, environ-
mental factors, processing and storage, and plant variety; lack of
information about some foods in the FFQ, especially for wholegrain
foods which could have, if anything, determined an underestima-
tion of the intake of some polyphenols masking some differences.
In conclusion, the resultsof this studyare relevantas theyshow, for
the ﬁrst time in peoplewith type 2 diabetes, that a diet characterized
by a higher intake of polyphenols is associated with amore favorable
cardiovascular risk factor proﬁle, and less subclinical inﬂammation.
This is true even if the intake of polyphenols is not particularly high in
our population compared to others. This should encourage the use of
foodsandbeveragesrich indifferentclassesofpolyphenolsalso in this
category of patients as in the general population.
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